---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-216056"
form_type: "8-K"
ticker: "TXMD"
cik: "0000025743"
company_name: "TherapeuticsMD, Inc."
filed_at: "2023-08-18T23:59:59+00:00"
generated_at: "2026-06-11T07:09:48.558263+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# TherapeuticsMD appoints Joseph Ziegler as Principal Financial Officer after resignation of Michael Donegan

## Summary
- Entered Master Services Agreement with JZ Advisory Group for $10,000/month plus 7,500 restricted stock units for Joseph Ziegler as Principal Financial Officer
- Michael Donegan resigned as Principal Financial and Accounting Officer effective August 17, 2023
- Joseph Ziegler, founder of JZ Advisory Group, succeeded Donegan; previously CFO at DAS Health and Encompass Onsite
- Agreement has a three-year term with automatic renewal unless either party provides 30-day non-extension notice

## SEC filing metadata
- accession: 0001193125-23-216056
- form_type: 8-K
- ticker: TXMD
- cik: 0000025743
- company_name: TherapeuticsMD, Inc.
- filed_at: 2023-08-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/25743/000119312523216056/0001193125-23-216056-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/25743/000119312523216056/d462055d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-216056
- JSON: https://secwatch.observer/filing/0001193125-23-216056.json
- Plain text: https://secwatch.observer/filing/0001193125-23-216056.txt

## Key facts
- Executive change
  Michael C. Donegan resigned as Principal Financial and Accounting Officer at TherapeuticsMD, Inc..
  - Action: resigned
  - Role: Principal Financial and Accounting Officer
  source text: On August 17, 2023, Mr. Michael C. Donegan, the Principal Financial and Accounting Officer of the Company, notified the Company of his decision to resign from such positions, effective as of August 17, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/25743/000119312523216056/0001193125-23-216056-index.htm
- Executive change
  Joseph Ziegler was appointed as Principal Financial and Accounting Officer at TherapeuticsMD, Inc..
  - Action: succeeded
  - Role: Principal Financial and Accounting Officer
  source text: Mr. Ziegler succeeded Mr. Donegan as Principal Financial and Accounting Officer as of the effective date of Mr. Donegan’s resignation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/25743/000119312523216056/0001193125-23-216056-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.